Literature DB >> 18519707

Immunoglobulin allotypes influence antibody responses to mucin 1 in patients with gastric cancer.

Janardan P Pandey1, Paul J Nietert, Silvia von Mensdorff-Pouilly, Kersti Klaamas, Oleg Kurtenkov.   

Abstract

There are significant interindividual differences in naturally occurring antibody responses to the tumor-associated antigen mucin 1 (MUC1), but the host genetic factors that might contribute to these differences have not been identified. The aim of the present investigation was to determine whether the variation in naturally occurring antibody levels to MUC1 in patients with gastric cancer is associated with GM and KM allotypes, genetic markers of IgG heavy chains and kappa-type light chains, respectively. A total of 169 Caucasian subjects with gastric cancer were allotyped for several GM and KM markers. These subjects were also characterized for IgG and IgM antibodies to MUC1. GM 3 23 5,13 phenotype was highly significantly associated with MUC1 IgG levels; subjects with this phenotype had lower antibody levels compared with those lacking this phenotype (median IgG level 65.5 relative units versus 91.0 relative units, P = 0.0058). In addition, this phenotype had an interactive effect with KM phenotypes on the levels of IgG antibodies to this antigen (P = 0.0081). Levels of MUC1 IgM antibodies were not associated with these genetic markers. These results show, for the first time, that GM and KM allotypes contribute to the interindividual differences in humoral immunity to MUC1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18519707     DOI: 10.1158/0008-5472.CAN-07-5607

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Genetic regulation of antibody responses to human epidermal growth factor receptor 2 in breast cancer.

Authors:  Janardan P Pandey; Aryan M Namboodiri; Oleg Kurtenkov; Paul J Nietert
Journal:  Hum Immunol       Date:  2010-08-22       Impact factor: 2.850

2.  IGHG, IGKC, and FCGR genes and endogenous antibody responses to GARP in patients with breast cancer and matched controls.

Authors:  Janardan P Pandey; Aryan M Namboodiri; Kent E Armeson; Motoki Iwasaki; Yoshio Kasuga; Gerson S Hamada; Shoichiro Tsugane
Journal:  Hum Immunol       Date:  2018-06-04       Impact factor: 2.850

3.  Endogenous antibody responsiveness to epidermal growth factor receptor is associated with immunoglobulin allotypes and overall survival of patients with glioblastoma.

Authors:  Janardan P Pandey; Emily Kistner-Griffin; Faisal F Radwan; Navtej Kaur; Aryan M Namboodiri; Laurel Black; Mary Ann Butler; Tania Carreon; Avima M Ruder
Journal:  Neuro Oncol       Date:  2014-10-17       Impact factor: 12.300

4.  A genetic variant of FcγRIIIa is strongly associatedwith humoral immunity to cyclin B1 in African American patients with prostate cancer.

Authors:  Janardan P Pandey; Aryan M Namboodiri; Emily Kistner-Griffin
Journal:  Immunogenetics       Date:  2012-11-01       Impact factor: 2.846

5.  Genetic variants of immunoglobulin γ and κ chains influence humoral immunity to the cancer-testis antigen XAGE-1b (GAGED2a) in patients with non-small cell lung cancer.

Authors:  J P Pandey; A M Namboodiri; Y Ohue; M Oka; E Nakayama
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

6.  Surprising negative association between IgG1 allotype disparity and anti-adalimumab formation: a cohort study.

Authors:  Geertje M Bartelds; Els de Groot; Michael T Nurmohamed; Margreet H L Hart; Peter H van Eede; Carla A Wijbrandts; Jakob B A Crusius; Ben A C Dijkmans; Paul Peter Tak; Lucien Aarden; Gerrit J Wolbink
Journal:  Arthritis Res Ther       Date:  2010-12-27       Impact factor: 5.156

7.  The forgotten tale of immunoglobulin allotypes in cancer risk and treatment.

Authors:  Janardan P Pandey; Zihai Li
Journal:  Exp Hematol Oncol       Date:  2013-02-20

8.  Natural and Induced Humoral Responses to MUC1.

Authors:  Silvia Von Mensdorff-Pouilly; Maria Moreno; René H M Verheijen
Journal:  Cancers (Basel)       Date:  2011-07-29       Impact factor: 6.639

9.  MS-Based Allotype-Specific Analysis of Polyclonal IgG-Fc N-Glycosylation.

Authors:  Thomas Sénard; Andrea F G Gargano; David Falck; Steven W de Taeye; Theo Rispens; Gestur Vidarsson; Manfred Wuhrer; Govert W Somsen; Elena Domínguez-Vega
Journal:  Front Immunol       Date:  2020-08-21       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.